Alnylam Pharmaceuticals Aktie
286,10
EUR
+10,60
EUR
+3,85
%
334,00
USD
+3,23
USD
+0,98
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung